Rome-based biomedical university specializing in neuroprosthetics, neural interfaces, assistive robotics, and spinal regenerative medicine.
Campus Bio-Medico University of Rome is a biomedical engineering-focused university that specializes in neuroprosthetics, neural interfaces, and human-robot interaction. Their core work bridges neuroscience and robotics — designing prosthetic hands with sensory feedback, brain-computer interfaces for motor augmentation, and robotic systems for rehabilitation. They also contribute to regenerative medicine research, particularly spinal disc repair using stem cells and cell therapies. Their strength lies in translating neuroscience insights into functional assistive devices and therapies.
Core expertise demonstrated across RESHAPE (coordinated, ERC-funded prosthetic hand embodiment), DeTOP (osseointegrated prosthesis), SOMA (peripheral interfaces for somatosensory feedback), and STIMBOY (robotic transcranial stimulation).
Spans AIDE (adaptive multimodal interfaces for disabled people), CONBOTS (robot-mediated handwriting/music learning), NIMA (non-invasive movement augmentation), and RESHAPE (prosthetic embodiment).
Participant in both RESPINE (MSC therapy for disc disease) and iPSpine (iPSC-based spinal regeneration), contributing biomaterials and preclinical model expertise.
FIDELIO training network studying bone fragility in diabetes, spanning epidemiology, microbiome interactions, and personalized medicine approaches.
ODIN project applying AI to transform healthcare delivery and hospital efficiency across European leading hospitals.
In the early period (2015–2018), Campus Bio-Medico focused squarely on robotic prosthetics and neural interfaces — building exoskeletons, prosthetic hands, and adaptive assistive devices for disabled people. From 2019 onward, their work branched in two directions: they deepened their neurotechnology expertise (brain-computer interfaces, motor augmentation, robotic stimulation) while expanding into regenerative medicine and chronic disease research (spinal disc therapy, bone fragility in diabetes, AI-enabled hospital systems). This evolution suggests a university growing from a robotics-and-prosthetics lab into a broader biomedical engineering institution with clinical ambitions.
They are moving toward closed-loop neurorehabilitation systems that combine neural interfaces with regenerative therapies and AI — a strong fit for future projects blending digital health with biomedical devices.
Campus Bio-Medico operates mostly as an active research partner (8 of 11 projects), but steps up as coordinator for their core neuroprosthetics work — all three coordinated projects (RESHAPE, SOMA, STIMBOY) involve neural interfaces and prosthetics. With 96 unique partners across 19 countries, they maintain a broad European network rather than relying on repeat collaborators. This makes them a well-connected partner who brings deep technical expertise without demanding the lead role, though they can credibly coordinate when the topic aligns with their specialty.
Extensive European network spanning 96 unique consortium partners across 19 countries, reflecting participation in mid-to-large consortia in both digital and health domains. No obvious geographic concentration — they collaborate pan-European rather than clustering within Mediterranean partnerships.
Campus Bio-Medico sits at an uncommon intersection: they combine neuroscience, robotics engineering, and clinical medicine within a single university. Most neuroprosthetics groups are either pure engineering (building devices) or pure neuroscience (understanding the brain) — this team does both and tests outcomes in clinical settings. Their ERC-funded RESHAPE project on prosthetic hand embodiment exemplifies this: it spans brain stimulation, peripheral nerve interfaces, and functional hand prostheses in one programme.
